Notes on Contributors
Donald M. Berwick, MD, MPP, FRCP, is president emeritus and senior fellow at the Institute for Healthcare Improvement, an organization that Berwick cofounded and led as president and CEO for 18 years. In July 2010, President Obama appointed Berwick to the position of administrator of the Centers for Medicare and Medicaid Services, which he held until December 2011. A pediatrician by background, Berwick has served as clinical professor of pediatrics and health care policy at the Harvard Medical School and professor of health policy and management at the Harvard School of Public Health. He is an elected member of the National Academy of Medicine. Berwick is the author or coauthor of over 160 scientific articles and 6 books. He is now a lecturer in the Department of Health Care Policy at Harvard Medical School.
Helen Cheyne, PhD, MSc, RGN, RM, is professor of maternal and child health research in the Nursing, Midwifery and Allied Health Professions Research Unit at the University of Stirling. Cheyne is a midwife with experience in both urban and rural maternity units. Her research interests include realist evaluation, improving models of service delivery, mothers’ experiences of maternity care, and health care decision making.
Emma Coles, PhD, MSc, MA, is a research fellow in the Nursing, Midwifery and Allied Health Professions Research Unit at the University of Stirling. Coles is currently working on a maternal and early years well-being, health, and inequalities study, using realist synthesis methodology to explore how and why early years interventions work or do not work in given contexts and with what outcomes and effects. Her research interests include health inequalities and health promotion.
Brigid Daniel, PhD, CQSW, MA, is professor of social work at the University of Stirling and director of the Stirling Centre for Child Wellbeing and Protection. Her main research interests and publications are in child neglect, children’s resilience, and critical analysis of child welfare and protection practice. Daniel is currently working on a study of outcomes for children removed from home under the age of 5 and a comparative study of 4 UK countries led by Coventry University on identifying and understanding inequalities in child welfare intervention rates. She has written books on child development, work with fathers, children’s resilience, and child neglect, including Child Development for Child Care and Protection Workers (Jessica Kingsley Publishing, 2010).
Yao Ding, PhD, is a researcher in the life science group of Truven Health Analytics. Her research focuses on using retrospective designs to conduct economic modeling studies, administrative claims-based analyses, and literature reviews, including global and local-market value dossiers. Prior to joining Truven, she completed a research fellowship in health economics at the Association of Public Health Laboratories, where she worked closely with her mentor at the Centers for Disease Control and Prevention and staff from state governments on economic evaluations of newborn screening strategies. She received a PhD in pharmaceutical economics and policy from University of Southern California. Her dissertation examined the advances and applications for economic evaluation methods in health technology assessment.
Daniel M. Fox, PhD, an author, policy adviser, mentor, and visiting faculty member, is president emeritus of the Milbank Memorial Fund. He has, since 1961, been publishing articles and books in the literatures of health services research, health and social policy, law, medicine, economic, cultural and intellectual history, and the history of medicine and health. His most recent book is The Convergence of Science and Governance: Research, Health Policy and American States (University of California Press, 2010). Fox has served in three federal agencies, in government in two states, and as a faculty member and administrator at Harvard and Stony Brook University. He is a member of the National Academies of Medicine and Social Insurance and of the Council on Foreign Relations. He holds AB, AM, and PhD degrees from Harvard University.
Michael Glass began his career at the Washington State Department of Health in 1969 as a laboratory technician providing glassware to the recently created newborn screening unit. He later worked as a microbiologist performing PKU screening and was promoted to supervisor in 1979. Under his leadership the laboratory added more disorders along with numerous quality and process improvements. The newborn screening test for congenital adrenal hyperplasia was developed under his guidance and Washington State was the first program to screen all newborns for this condition. Washington State was also a pioneer in using DNA technology as a second-tier analysis for hemoglobinopathies in 1991. When he retired in 2014 the program was screening for 28 different conditions.
Lawrence O. Gostin, JD, is University Professor in Global Health Law at Georgetown University, faculty director of the O’Neill Institute for National and Global Health Law, and director of the World Health Organization (WHO) Collaborating Center on Public Health Law and Human Rights. He has chaired numerous National Academy of Sciences committees, proposed a Framework Convention on Global Health endorsed by the United Nations Secretary-General, served on the WHO Director-General’s Ad Hoc Advisory Committee on Reforming the WHO, drafted a Model Public Health Law for the WHO and the Centers for Disease Control and Prevention, and directed the National Council of Civil Liberties and the National Association for Mental Health in the United Kingdom, where he wrote the Mental Health Act and brought landmark cases before the European Court of Human Rights. In the United Kingdom, he was awarded the Rosemary Delbridge Prize for the person “who has most influenced Parliament and government to act for the welfare of society.”
Trisha Greenhalgh, MD, BM Bch, MBA, is professor of primary care health sciences, University of Oxford, UK. Her work seeks to celebrate and retain the traditional and the humanistic aspects of medicine and health care while also embracing the unparalleled opportunities of contemporary science and technology to improve health outcomes and relieve suffering. Three particular interests are the health needs and illness narratives of minority and disadvantaged groups; the introduction of technology-based innovations in health care; and the complex links (philosophical and empirical) between research, policy, and practice.
Scott Grosse, PhD, is research economist in the National Center on Birth Defects and Developmental Disabilities at the Centers for Disease Control and Prevention (CDC). He has a PhD in public health from the University of Michigan and joined the CDC in 1996. He has authored more than 150 publications on health services research and economic evaluation methods and empirical and policy analyses of health outcomes and economic costs. Recent publications include economic assessments of folic acid fortification, genetic testing for Lynch syndrome, venous thromboembolism, and newborn screening for conditions such as cystic fibrosis, phenylketonuria, severe combined immune deficiency, and sickle cell disease.
Claire Jackson, MBBS, MD, MPH, is professor in general practice and primary care research and director of the Centres for Primary Care Reform Research Excellence at the University of Queensland. Jackson is the director of two $2.5 million Centres of Research Excellence—one exploring new models of integrated care between hospital and community and the other investigating the impact of researcher and end-user “co-creation” on quality and models of care. Her primary area of research interest is in health system reform involving primary care, a topic on which she has published and presented internationally.
Tina Janamian, PhD, MBA, MMedSc, is director of strategic research and partnership development for the Centre of Research Excellence in primary care to support Australia’s health care reform. Her work involves providing robust management and research expertise across multi-institutional programs to achieve quality outcomes. She also focuses on identifying long-term opportunities and aligning organizational operations and strategies with end-user needs. This is achieved by effectively collaborating with a range of stakeholders and strengthening partnerships with industry, health care professionals, policymakers, and consumers to maximize co-created outcomes of value for all stakeholders and improve research translation into policy and practice.
Rebecca Katz, PhD, MPH, is an associate professor in the Milken Institute School of Public Health at George Washington University. In 2007, she received a K01 award from the Centers for Disease Control and Prevention to perform a comparative study of international law and public health preparedness, and has since focused her research on the implementation of the International Health Regulations, health diplomacy, and public health preparedness policy.
Greg Kotzbauer, MS, is the managing director of strategic technology initiatives at The Dartmouth Institute for Health Policy and Clinical Practice. Kotzbauer’s career mission is to meaningfully contribute to the design and creation of a value-oriented health system that promotes personally relevant health outcomes for all. To support this mission he is focused on producing novel analytic models that accelerate the transition to aligned partnerships between patients and providers, lower per capita health care cost, and optimal population health under value-oriented payment models.
Jean Rankin, PhD, MMedSc, BSc, RN, RM, RSCN, is professor of maternal, child, and family health at the University of West Scotland. She has worked in higher education for 20 years. Her current role is in nursing and midwifery research, including a range of funded studies focusing on vulnerable adolescents, the NHS nursing and midwifery workforce, building research capacity, facilitating the implementation of the Scottish government’s “early years” policies into everyday practice in the NHS, and rural midwifery education.
Sara Shaw, PhD, is senior researcher in the Nuffield Department of Primary Care Health Sciences at the University of Oxford. She has a background in medical sociology and policy studies and extensive experience of developing and applying qualitative approaches to studying health policy. She has a particular interest in exploring how organizational processes, routines, and decision making are created through language/social interaction and shape health care. Shaw is committed to working across social, political, and organizational boundaries. In addition to her position at the University of Oxford, Shaw is visiting reader at Queen Mary, University of London and visiting senior fellow at the Nuffield Trust, an independent UK charity focused on researching health policy and the organization and delivery of health care.
John D. Thompson received a bachelor’s degree from Brigham Young University in molecular biology in 1999. He pursued concurrent master’s degrees in public administration and public health genetics at the University of Washington. His research focused on newborn screening policy. Thompson finished his PhD in public health genetics from the University of Washington in 2008. His dissertation examined the impact of the choice of newborn screening strategies for cystic fibrosis on newborn screening programs and individual families. Thompson joined the Washington State Newborn Screening Program in 2003 as a follow-up consultant and now supervises the short-term follow-up group in Washington State. He loves using data for program evaluation and quality assurance. He is happily married with five wonderful children.
William B. Weeks, MD, PhD, MBA, is professor of psychiatry and community and family medicine at the Geisel School of Medicine at Dartmouth. He works at The Dartmouth Institute for Health Policy and Clinical Practice, where he teaches in master’s programs and conducts research on alternative models of health care delivery, health economics, and health care value. He has published more than 150 peer-reviewed manuscripts examining economic and business aspects of health care services utilization and delivery, health care delivery science, and health care value, and was honored with the 2008 National Rural Health Association Outstanding Researcher Award, the 2016 Jerome F. McAndrews Award for excellence in research, and the 2016 Fulbright- Toqueville Distinguished Chair Award and IMéRA Visiting Professor at Aix-Marseille University.
James N. Weinstein, DO, MS, is CEO and president of Dartmouth- Hitchcock health system where he is a leader in advancing “informed choice” to ensure patients receive evidence-based, safe, effective, efficient, and appropriate care. He is a member of the National Academy of Medicine, an Ellis Island Medal of Honor recipient, and has been named one of “The 100 Most Influential People in Healthcare” by Modern Healthcare magazine. He holds the Peggy Y. Thomson Chair in the Evaluative Clinical Sciences at Geisel School of Medicine at Dartmouth. Weinstein received his DO in osteopathic medicine from the Chicago College of Osteopathic Medicine, and his MS in health services research from Dartmouth Medical School.
Volume 94, Issue 2 (pages 430–435)
Published in 2016